期刊文献+

宫腔镜联合左炔诺孕酮宫内节育系统治疗异常子宫出血的临床效果

Clinical Effect of Hysteroscopy Combined with Levonorgestrel Intrauterine System in the Treatment of Abnormal Uterine Bleeding
下载PDF
导出
摘要 目的:研究宫腔镜+左炔诺孕酮宫内节育系统运用于异常子宫出血中的价值。方法:选择罗定市中医院2020年1月-2021年2月收治的异常子宫出血患者70例,按随机数字表法分为两组,各35例,研究组接受宫腔镜+左炔诺孕酮宫内节育系统,对照组接受宫腔镜,对比两组总有效率、治疗前后测定两组的孕酮、促卵泡生成激素、雌二醇、促黄体生成激素、月经时间、月经量、子宫内膜厚度、孕激素受体(PR)、雌激素受体(ER)、血管内皮生长因子(VEGF)指标,并统计两组不良反应发生率。结果:治疗后3个月,研究组总有效率为91.43%,高于对照组的71.43%(P<0.05)。治疗前两组性激素指标比较,差异均无统计学意义(P>0.05),治疗后3个月,研究组孕酮、促卵泡生成激素、雌二醇、促黄体生成激素均低于对照组(P<0.05)。治疗前两组月经时间、月经量、子宫内膜厚度相比,差异均无统计学意义(P>0.05),治疗后3个月,研究组月经时间短于对照组,月经量少于对照组,子宫内膜厚度薄于对照组(P<0.05)。治疗后3个月,研究组不良反应发生率为8.57%,与对照组的17.14%相比,差异无统计学意义(P>0.05)。治疗前两组PR、ER、VEGF相比,差异均无统计学意义(P>0.05),治疗后3个月,研究组PR、ER均低于对照组,但VEGF高于对照组(P<0.05)。结论:宫腔镜+左炔诺孕酮宫内节育系统运用于异常子宫出血中疗效显著,促进性激素水平恢复,改善子宫内膜厚度及月经状况,调节PR、ER,防止严重不良反应出现。 Objective:To study the value of hysteroscopy+Levonorgestrel Intrauterine System in the treatment of abnormal uterine bleeding.Method:A total of 70 patients with abnormal uterine bleeding in Luoding Hospital of Traditional Chinese Medicine from January 2020 to February 2021 were randomly divided into two groups with 35 cases in each group.The study group received hysteroscopy+Levonorgestrel Intrauterine System and the control group received hysteroscopy.The total effective rates of the two groups were evaluated.The progesterone,follicle stimulating hormone,estradiol,luteinizing hormone,menstrual time,menstrual volume,endometrial thickness,progesterone receptor(PR),estrogen receptor(ER),vascular endothelial growth factor(VEGF)of the two groups were measured before and after treatment,the incidence of adverse reactions in the two groups were counted.Result:Three months after treatment,the total effective rate in the study group was 91.43%,which was higher than 71.43%in the control group(P<0.05).There were no differences in sex hormone indexes between the two groups before treatment(P>0.05).Three months after treatment,progesterone,follicle stimulating hormone,estradiol and luteinizing hormone in the study group were lower than those in the control group(P<0.05).There were no differences in the menstrual time,menstrual volume and endometrial thickness between the two groups before treatment(P>0.05).Three months after treatment,the menstrual time of the study group was shorter than that of the control group,menstrual volume was less than that of the control group,and endometrial thickness of the study group was thinner than that of the control group(P<0.05).Three months after treatment,the adverse reactions in the study group were 8.57%and 17.14%in the control group,there was no significant difference(P>0.05).There was no difference in PR,ER,and VEGF between the two groups before treatment(P>0.05).Three months after treatment,PR and ER in the study group were lower than those in the control group,but VEGF was higher than that in the control group(P<0.05).Conclusion:Hysteroscopy+Levonorgestrel Intrauterine System is effective in abnormal uterine bleeding,promote the recovery of sex hormone level,improve endometrial thickness and menstrual status,regulate PR and ER,and prevent serious adverse reactions.
作者 孔惠玲 KONG Huiling(Luoding Hospital of Traditional Chinese Medicine,Guangdong Province,Luoding 527200,China)
出处 《中国医学创新》 CAS 2023年第13期1-5,共5页 Medical Innovation of China
关键词 左炔诺孕酮宫内节育系统 异常子宫出血 宫腔镜 Levonorgestrel Intrauterine System Abnormal uterine bleeding Hysteroscopy
  • 相关文献

参考文献16

二级参考文献149

  • 1黄雪坤,尚慧玲,张四友,李光仪.促性腺激素释放激素激动剂联合监测排卵治疗子宫腺肌症合并不孕症的疗效观察[J].中华临床医师杂志(电子版),2011,5(11):3326-3328. 被引量:7
  • 2Fraser IS,Critchley HO,Broder M,et al.The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding[J].Semin Reprod Med,2011,29:383-390.
  • 3Munro MG,Critchley HO,Fraser IS.The FIGO classification of causes of abnormal uterine bleeding in the reproductive years[J].Fertil Steril,2011,95:2204-2208.
  • 4中华医学会妇产科学分会内分泌学组,中华医学会妇产科学分会绝经学组.功能失调性子宫出血临床诊断治疗指南(草案)[J].中华妇产科杂志,2009,44:234-236.
  • 5Salim S,Won H,Nesbitt-Hawes E,et al.Diagnosis andmanagement of endometrial polyps:a critical review of theliterature[J].J Minim Invasive Gynecol,2011,18:569-581.
  • 6Gardner F J,Konje JC,Bell SC,et al.Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial[J].Gynecol Oncol,2009,114:452-456.
  • 7Weiss G,Maseelall P,Schott LL,et al.Adenomyosis a variant,not a disease? Evidence from hysterectomized menopausal women in the Study of Women' s Health Across the Nation (SWAN)[J].Fertil Steril,2009,91:201-206.
  • 8Morelli M,Rocca ML,Venturella R,et al.Improvement in chronic pelvic pain after gonadotropin releasing hormone analogue (GnRH-a) administration in premenopausal women suffering from adenomyosis or endometriosis:a retrospective study[J].Gynecol Endocrinol,2013,29:305-308.
  • 9Malek-Mellouli M,Ben AF,Youssef A,et al.Hysteroscopic myomectomy[J].Tunis Med,2012,90:458-462.
  • 10Kim ML,Seong SJ.Clinical applications of levonorgestrelreleasing intrauterine system to gynecologic diseases[J].Obstet Gynecol Sci,2013,56:67-75.

共引文献630

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部